Competing interests JC: provided consultation to Acadia, Actinogen, Acumen, Alpha Cognition, Aprinoia, AriBio, Artery, Biogen, BioVie, Cassava, Cerecin, Diadem, EIP Pharma, Eisai, GemVax, Genentech, GAP Innovations, Janssen, Jocasta, Karuna, Lilly, Lundbeck, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Optoceutics, Ono, Otsuka, PRODEO, Prothena, reMYND, Roche, Sage Therapeutics, Signant Health, Simcere, Suven, SynapseBio, TrueBinding, Vaxxinity, and Wren Therapeutics
Diabetes (2010) 59:176570
Maintenance Dosage: For ongoing management of weight loss, once you've found the dose that works best for you with the least side effects, you'll likely stay at that dose long-term
For this study (NCT05819853), a total of 27 patients with a diagnosis of PCOS and obesity who did not reduce their body weight via a lifestyle modification program were treated with 0.5 mg of subcutaneous semaglutide weekly